Skip to main content
Download PDF
  • Systematic Review
  • Open access
  • Published:

Risk factors for neonatal hypoglycemia: a meta-analysis

BMC Endocrine Disorders volume 24, Article number: 166 (2024) Cite this article

Abstract

Objective

This Study aims to investigate the risk factors of hypoglycemia in neonates through meta-analysis.

Method

PubMed, Embase, Cochrane library, and Web of science databases were searched for case-control studies on risk factors for neonatal hypoglycemia. The search was done up to 1st October 2023 and Stata 15.0 was used for data analysis.

Results

A total of 12 published studies were included, including 991 neonates in the hypoglycemic group and 4388 neonates in the non-hypoglycemic group. Meta-analysis results suggested caesarean section [OR = 1.90 95%CI (1.23, 2.92)], small gestational age[OR = 2.88, 95%CI (1.59, 5.20)], gestational diabetes [OR = 1.65, 95%CI (1.11, 2.46)], gestational hypertension[OR = 2,79, 95%CI (1.78, 4.35)] and respiratory distress syndrome[OR = 5.33, 95%CI (2.22, 12.84)] were risk factors for neonatal hypoglycemia.

Conclusion

Based on the current study, we found that caesarean section, small gestational age, gestational diabetes, gestational hypertension, respiratory distress syndrome are risk factors for neonatal hypoglycemia.

PROSPERO registration number

CRD42023472974.

Peer Review reports

Introduction

In the realm of neonatal health, neonatal hypoglycemia has emerged as a prevalent metabolic ailment affecting newborns [1]. Evidently, neonatal hypoglycemia has been designated as a substantial peril, attributing to an array of adverse neurodevelopmental outcomes, including learning disabilities, attention deficit, developmental delay, hyperactivity, epilepsy, and autism, particularly in neonates with blood glucose levels measuring below 2.6 mmol/L, irrespective of gestational age, weight [2,3,4]. The incidence of this condition spans from 5 to 15% among typical neonates, surging to as high as 50% among those born with notable risk factors [5, 6]. The neonatal phase encapsulates the critical transition from in utero reliance on the maternal system to autonomous metabolic regulation upon birth [7]. The constancy of blood glucose levels hinges upon factors encompassing glucose utilization, hepatic and renal glycogen catabolism, activation of gluconeogenic metabolic pathways, and the provisioning of exogenous glucose. Thus, insufficiency in glycogen reserves, heightened consumption, limited gluconeogenic capacity, and inadequate external glucose supply can collectively precipitate hypoglycemia. Crucially, glucose constitutes the primary energy source for cerebral metabolism, rendering the brain susceptible to harm when glucose availability wanes [8, 9]. The risk of hypoglycemic brain injury is further intertwined with the duration of hypoglycemia and the amplitude of glycemic fluctuations. Given the dynamic growth and development of the neonatal brain, diminished blood glucose levels entail a heightened vulnerability, amplifying the odds of neurological impairment [10].

Detecting neonatal hypoglycemia presents a formidable challenge, as its clinical manifestations are notably non-specific, encompassing symptoms such as lethargy, altered gaze, irritability, seizures, feeding difficulties, respiratory distress, cyanosis [11, 12]. The American Academy of Pediatrics underscores the identification of risk factors as the linchpin in averting severe neurological consequences. Recent investigations into risk factors associated with neonatal hypoglycemia have, however, yielded disparate results, fostering an element of controversy [13]. Hence, the primary objective of this investigation is to undertake a thorough meta-analysis of preexisting research concerning the risk factors correlated with neonatal hypoglycemia. The overarching goal of this endeavor is to pinpoint the risk factors contributing to neonatal hypoglycemia and to establish a foundation for early preventive measures.

Method

This study was registered in the PROSPERO International Prospective Register of Systematic Reviews (Registration number: CRD42023472974), and is reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [14].

Literature retrieval

The databases PubMed, Embase, Cochrane library, and Web of science were searched for case-control studies on risk factors for hypoglycemia in newborn infants, the search time was from the start of each database establishment until October 1, 2023. The search was performed using subject terms plus free words: infant, newborn, hypoglycemia, risk factors, and the specific search strategy is described in Supplementary Material 1.

Criteria for inclusion and exclusion

Inclusion criteria: Case-control study of neonates (including gestational age < 37 weeks) who met the diagnostic criteria for hypoglycemia [15]. The primary outcome indicators were unifactorial and multifactorial risk factor analyses, without qualifying unifactorial analyses versus multifactorial factor analyses, but when both unifactorial and multifactorial results were included in the same paper, multifactorial results were preferred and multifactorial adjusted risk values were extracted, or if only unifactorial analyses were available, unifactorial results were extracted.

Exclusion criteria: conference abstracts, protocols, letters, repetitive publications, systematic reviews, inaccessibility of full text, inaccessibility of available data, animal experiments.

Data extraction

Two independent reviewers independently screened the literature to extract the data, read the title and abstract of the literature, as well as the full text, and directly screen the literature that is easy to judge; For the literature that can be included with objections, consult relevant experts for opinions, and screen by directly downloading and reading the full text. In the screening process, the inclusion and exclusion criteria are strictly followed, the corresponding indicators in the study are extracted, and the extracted data are cross-checked to ensure the consistency of the extracted data. The main contents of data extraction include: first author, year of publication, country, sample size, sex, gestational age.

Risk of bias

The Newcastle-Ottawa Scale (NOS) [16] was used to evaluate the case-control study, including selection of study population (4 points), comparability between groups (2 points), exposure factors or outcome measures (3 points). The total score of the scale is 9 points, ≤ 4 is classified as low quality, 5–6 is classified as medium quality, and ≥ 7 is classified as high quality. If the two researchers have differences in the evaluation process, they will discuss the decision or ask the third party to decide.

Statistical analysis

Stata15.0 was used for statistical analysis of the data. Our univariate analyses for comparing baseline values in the case and non-case groups. Multivariate analyses were performed by combining the OR, RR or HR and 95% confidence intervals for each article. The risk value of each study was not distinguished by OR, RR or HR, but was described by OR value. The aggregate OR value and 95% confidence interval were calculated. According to the results of heterogeneity test (Q-test method) and I2 statistic [17], the corresponding model was selected to calculate the combined OR value. If I2 > 50%, the random effects model was used; if I2 ≤ 50%, the fixed effects model was used. With I2 > 50% [18], Sensitivity analysis was performed by eliminating literature one by one for indicators with large heterogeneity, and publication bias was analyzed by the Egger test, with the test level α = 0.05. P < 0.05 was statistically significant [19].

Result

Literature search results

The search of PubMed, Embase, Cochrane library, and Web of science databases initially yielded 1964 documents, 1384 documents were obtained by removing duplicates, 17 articles were obtained by reading the titles and abstracts for initial screening, and 12 articles [20,21,22,23,24,25,26,27,28,29,30,31] were finally included by reading the full text, and the specific flowchart of the search is shown in Fig. 1.

Fig. 1
figure 1

Flow chart of literature search

Full size image

Characteristics of included documents

Twelve articles [20,21,22,23,24,25,26,27,28,29,30,31] were included, four [22, 23, 25, 30] from China, two [20, 31] from Indonesia, one [28] from Japan, one [29] from Australia, one from [27] India, and one [24] from the Netherlands. There were 991 in the hypoglycemic group and 4388 in the non-hypoglycemic group, and the specific literature characteristics are tabulated in Table 1.

Table 1 Literature characteristics table
Full size table

Twelve articles were included using the NOS quality assessment, with one [21] scoring 6, a medium quality study. The rest scored 7–8, with overall high quality of the included studies. Specific quality ratings are shown in Table 2.

Table 2 NOS score
Full size table

Univariate meta-analysis

Caesarean section

Caesarean section was mentioned in 9 articles [20,21,22,23,24,25,26,27, 30], and the test of heterogeneity (I2 = 82.2%,P = 0.001) was analyzed using a random effects model, and the results of the analysis suggested that caesarean section was a risk factor for hypoglycemia in neonates, and the difference was statistically significant [OR = 1.90 95%CI (1.23, 2.92) ], Fig. 2; Table 3.

Fig. 2
figure 2

Forest plot of caesarean section

Full size image
Table 3 Univariate meta-analysis
Full size table

Small gestational age

Small gestational age was mentioned in 8 articles [21, 23,24,25,26,27, 30, 31], and the test of heterogeneity (I2 = 82%,P = 0.001) was analyzed using a random effects model, and the results of the analysis suggested that small gestational age was a risk factor for hypoglycemia in neonates, and the difference was statistically significant [OR = 2.88, 95%CI (1.59, 5.20) ], Fig. 3; Table 3.

Fig. 3
figure 3

Forest plot of small gestational age

Full size image

Gestational diabetes

Gestational diabetes was mentioned in 9 articles [21, 23,24,25,26,27,28,29,30], and the test of heterogeneity (I2 = 62.8%,P = 0.006) was analyzed using a random effects model, and the results of the analysis suggested that gestational diabetes was a risk factor for hypoglycemia in neonates, and the difference was statistically significant [OR = 1.65, 95%CI (1.11, 2.46) ], Fig. 4; Table 3.

Fig. 4
figure 4

Forest plot of gestational diabetes

Full size image

Gestational hypertension

Gestational hypertension was mentioned in 7 articles [21, 24,25,26,27, 29, 30], and the test of heterogeneity (I2 = 67%,P = 0.006) was analyzed using a random effects model, and the results of the analysis suggested that gestational hypertension was a risk factor for hypoglycemia in neonates, and the difference was statistically significant [OR = 2,79, 95%CI (1.78, 4.35) ], Fig. 5; Table 3.

Fig. 5
figure 5

Forest plot of gestational hypertension

Full size image

Respiratory distress syndrome

Respiratory distress syndrome was mentioned in 5 articles [21, 25, 27, 29, 30], and the test of heterogeneity (I2 = 84.3%,P = 0.001) was analyzed using a random effects model, and the results of the analysis suggested that respiratory distress syndrome was a risk factor for hypoglycemia in neonates, and the difference was statistically significant [OR = 5.33, 95%CI (2.22, 12.84) ], Fig. 6; Table 3.

Fig. 6
figure 6

Forest plot for respiratory distress syndrome

Full size image

Other factor meta-analysis

Gender, Large gestational age, Necrotizing enterocolitis, Mechanical ventilation, and Twins were not statistically significant in relation to neonatal hypoglycemia, as shown in Table 3.

Multivariate meta-analysis

Multivariate analysis showed that Gestational hypertension was a risk factor for neonatal hypoglycemia, and the difference was statistically significant [OR = 1.91, 95%CI (1.35, 2.71)] Fig. 7; Table 4. There was no significant difference between Gestational age deficiency (gestational age less than 37 weeks) and neonatal hypoglycemia [OR = 1.32, 95%CI (0.92, 1.90)].

Fig. 7
figure 7

Forest plot for multivariate analysis of gestational hypertension

Full size image
Table 4 Multivariate meta-analysis
Full size table

Publication bias

Small gestational age (P < 0.05) was found to have publication bias in the univariate meta-analysis by egger’s test for each risk factor. No publication bias was detected in any of the other univariate, multivariate meta-analyses Tables 3 and 4.

Discussion

The current study represents the inaugural meta-analysis dedicated to the exploration of risk factors associated with neonatal hypoglycemia. Through univariate and multivariate analyses, we have ascertained that neonatal hypoglycemia is significantly linked to several factors, including cesarean section, small gestational age, gestational diabetes, gestational hypertension, and neonatal respiratory distress syndrome.

In the context of gestational diabetes, maternal hyperglycemia impels the fetus to undergo enhanced glucose uptake, consequently stimulating fetal pancreatic β-cell proliferation and elevating insulin levels, ultimately culminating in fetal hyperinsulinemia [32, 33]. Following delivery, the fetus experiences an abrupt cessation in the maternal glucose supply, yet insulin levels remain elevated. The neonate’s limited capacity for glucose isomerism in the early postnatal period exacerbates the situation, thereby instigating neonatal hypoglycemia. Research indicates that neonatal hypoglycemia can affect as much as 30–50% of offspring born to mothers with gestational diabetes [34]. Gestational hypertension during pregnancy leads to reduced placental blood perfusion, impacting the oxygen and blood supply to the fetus, thus hindering fetal development in utero [35], Concurrently, ischemia and hypoxia diminish glycogen synthase activity, impairing fetal glycogen synthesis and substantially elevating the risk of hypoglycemia in neonates [36, 37]. Cesarean section procedures, often involving pre-operative fasting, lead to a marked decline in maternal blood glucose levels, consequently diminishing the glucose supply to the fetus and raising the risk of neonatal hypoglycemia [38, 39], This suggests a need for healthcare practitioners to carefully manage the timing of food and fluid intake for expectant mothers undergoing cesarean sections and consider preoperative glucose infusion, all the while intensifying the monitoring of fetal hypoxia to prevent neonatal hypoglycemia.

The stability of neonatal blood glucose levels is contingent on both maternal blood glucose and inherent regulatory mechanisms. Fetal glycogen storage begins in the second trimester of pregnancy, with adipose tissue differentiation commencing around 26 weeks of gestational age. As a result, preterm infants and those born prior to their gestational age may suffer from hypoglycemia due to inadequate glycogen and fat reserves, along with underdeveloped glycogen catabolism and isomerism processes [40], Given that most low-birth-weight neonates fall into these categories, it is advisable for healthcare professionals to encourage early breastfeeding initiation and proactive glucose supplementation, with shorter intervals between feeds yielding better results [41]. Neonatal respiratory distress syndrome (NRDS) is characterized by a delay in establishing regular respiration within 1 min of birth, often due to hypoxia. Hypoxia prompts anaerobic metabolism, diminishing glucose utilization, depleting glycogen stores, and ultimately precipitating neonatal hypoglycemia [42]. Some studies [43, 44] suggest that asphyxia is a prominent risk factor for neonatal hypoglycemia, emphasizing the importance of monitoring blood glucose in asphyxiated neonates in addition to tracking blood oxygen levels.

However, it’s crucial to acknowledge several limitations in this study. The small number of studies included, and a high degree of inter-study inconsistency may influence the robustness of our conclusions. Additionally, heterogeneity exists in the diagnostic criteria for neonatal hypoglycemia among the selected studies. Furthermore, the scarcity of common indicators for multifactorial analyses necessitates additional high-quality research and data to strengthen and refine our findings in the future.

Conclusion

Based on the current study, we found that caesarean section, small gestational age, gestational diabetes, gestational hypertension, respiratory distress syndrome are risk factors for neonatal hypoglycemia, and healthcare professionals should consider both maternal and neonatal factors when developing interventions. Therefore, it is recommended that healthcare professionals should consider both maternal and neonatal factors when developing relevant interventions.

Data availability

Data is provided within the manuscript or supplementary information files.

References

  1. Hubbard EM, Hay WW Jr. Term Newborn: Hypoglycemia Clin Perinatol. 2021;48(3):665–79.

    PubMed  Google Scholar 

  2. De Angelis LC, et al. Neonatal hypoglycemia and brain vulnerability. Front Endocrinol (Lausanne). 2021;12:634305.

    Article  PubMed  Google Scholar 

  3. Edwards T, Harding JE. Clinical aspects of neonatal hypoglycemia: a Mini Review. Front Pediatr. 2020;8:562251.

    Article  PubMed  Google Scholar 

  4. Roeper M, et al. Neonatal hypoglycemia: lack of evidence for a safe management. Front Endocrinol (Lausanne). 2023;14:1179102.

    Article  PubMed  Google Scholar 

  5. Chandrasekharan P, Lakshminrusimha S. Single dose of prophylactic oral dextrose gel reduces neonatal hypoglycaemia. Evid Based Med. 2017;22(2):62.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Harris DL, Weston PJ, Harding JE. Incidence of neonatal hypoglycemia in babies identified as at risk. J Pediatr. 2012;161(5):787–91.

    Article  CAS  PubMed  Google Scholar 

  7. Ramel S, Rao R. Hyperglycemia in extremely Preterm infants. Neoreviews. 2020;21(2):e89–97.

    Article  PubMed  Google Scholar 

  8. Edwards T, et al. Oral dextrose gel for the treatment of hypoglycaemia in newborn infants. Cochrane Database Syst Rev. 2022;3(3):pCd011027.

    Google Scholar 

  9. Irvine LM, Harris DL. What are the barriers preventing the screening and management of neonatal hypoglycaemia in low-resource settings, and how can they be overcome? Matern Health Neonatol Perinatol. 2023;9(1):8.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Pinchefsky EF, et al. Nutrition and management of glycemia in neonates with neonatal encephalopathy treated with hypothermia. Semin Fetal Neonatal Med. 2021;26(4):101268.

    Article  CAS  PubMed  Google Scholar 

  11. Beardsall K. Hyperglycaemia in the Newborn Infant. Physiol Verses Pathol Front Pediatr. 2021;9:641306.

    Google Scholar 

  12. Horwitz J, et al. Scoping review of evidence for managing postnatal hypoglycaemia. BMJ Open. 2022;12(2):e053047.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Kaiser JR, Beardsall K, Harris DL. Editorial: controversies in neonatal hypoglycemia. Front Pediatr. 2023;11:1236258.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Liberati A, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Giouleka S et al. Diagnosis and management of neonatal hypoglycemia: a Comprehensive Review of guidelines. Child (Basel), 2023. 10(7).

  16. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5.

    Article  PubMed  Google Scholar 

  17. Borenstein M, et al. Basics of meta-analysis: I(2) is not an absolute measure of heterogeneity. Res Synth Methods. 2017;8(1):5–18.

    Article  PubMed  Google Scholar 

  18. Borenstein M. In a meta-analysis, the I-squared statistic does not tell us how much the effect size varies. J Clin Epidemiol. 2022;152:281–4.

    Article  PubMed  Google Scholar 

  19. Egger M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Angelika D et al. The incidence of and risk factors for hyperglycemia and hypoglycemia in preterm infants receiving early-aggressive parenteral nutrition. Heliyon, 2023. 9(8).

  21. Butorac Ahel I et al. Incidence and risk factors for glucose disturbances in premature infants. Med (Kaunas), 2022. 58(9).

  22. Cao Y, et al. Analysis of risk factors of neonatal hypoglycemia and its correlation with blood glucose control of gestational diabetes mellitus: a retrospective study. Med (Baltim). 2023;102(35):e34619.

    Article  CAS  Google Scholar 

  23. Chen YS, et al. Identifying additional risk factors for early asymptomatic neonatal hypoglycemia in term and late preterm babies. Pediatr Neonatol. 2022;63(6):625–32.

    Article  PubMed  Google Scholar 

  24. Koolen MR, et al. Incidence and risk factors for early hypoglycemia in very preterm infants: the hyporisk study. Clin Nutr ESPEN. 2023;56:67–72.

    Article  PubMed  Google Scholar 

  25. Li C, Zhao J, Tan L. Analysis of risk factors related to hypoglycemia during neonatal surgery. J Clin Pediatr Surg. 2023;22(1):67–71.

    CAS  Google Scholar 

  26. Mitchell NA, et al. Incidence and risk factors for Hypoglycemia during fetal-to-neonatal transition in premature infants. Front Pediatr. 2020;8:34.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Sasidharan CK, Gokul E, Sabitha S. Incidence and risk factors for neonatal hypoglycaemia in Kerala, India. Ceylon Med J. 2004;49(4):110–3.

    Article  CAS  PubMed  Google Scholar 

  28. Shimokawa S et al. Incidence and risk factors of neonatal hypoglycemia after ritodrine therapy in premature labor: a retrospective cohort study. J Pharm Health Care Sci, 2019. 5.

  29. Thevarajah A, Simmons D. Risk factors and outcomes for neonatal hypoglycaemia and neonatal hyperbilirubinaemia in pregnancies complicated by gestational diabetes mellitus: a single centre retrospective 3-year review. Diabet Med. 2019;36(9):1109–17.

    Article  CAS  PubMed  Google Scholar 

  30. Yuan ZX, et al. [Risk factors for hypoglycemia in preterm infants with a gestational age of ≤ 32 weeks]. Zhongguo Dang Dai Er Ke Za Zhi. 2020;22(11):1154–8.

    PubMed  Google Scholar 

  31. Yunarto Y, Sarosa GI. Risk factors of neonatal hypoglycemia. Paediatr Indonesiana. 2019;59(5):252–6.

    Article  Google Scholar 

  32. Abdulrahman M, et al. A review of gestational diabetes mellitus management, risk factors, maternal and neonatal outcomes in two major maternity hospitals in the United Arab Emirates: a report from Dubai. J Neonatal Perinat Med. 2020;13(4):555–62.

    Article  Google Scholar 

  33. Bouchghoul H, et al. Transplacental transfer of glyburide in women with gestational diabetes and neonatal hypoglycemia risk. PLoS ONE. 2020;15(5):e0232002.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Holt RI, Lambert KD. The use of oral hypoglycaemic agents in pregnancy. Diabet Med. 2014;31(3):282–91.

    Article  CAS  PubMed  Google Scholar 

  35. Beunen K, et al. Type 1 diabetes-related autoimmune antibodies in women with gestational diabetes mellitus and the long-term risk for glucose intolerance. Front Endocrinol (Lausanne). 2022;13:973820.

    Article  PubMed  Google Scholar 

  36. Ngwezi DP et al. Temporal trends in Type 1, type 2, and gestational diabetes in pregnancy: impact of Rural Residence, ethnicity, and Material Deprivation. Can J Diabetes, 2023.

  37. Salguero MV, et al. Novel KDM6A Kabuki Syndrome Mutation with Hyperinsulinemic Hypoglycemia and Pulmonary Hypertension requiring ECMO. J Endocr Soc. 2022;6(4):bvac015.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Priyanka P, et al. Vaginal birth as compared with cesarean section in preterm twins-experience from a tertiary center of a middle-income country. Int J Gynaecol Obstet. 2023;161(2):560–7.

    Article  PubMed  Google Scholar 

  39. Zeng R, et al. Application of glycemic qualification rate based on fingerstick glucose monitoring in women with gestational diabetes mellitus. J Matern Fetal Neonatal Med. 2023;36(1):2203797.

    Article  PubMed  Google Scholar 

  40. Stomnaroska O, et al. Neonatal hypoglycemia: risk factors and outcomes. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2017;38(1):97–101.

    PubMed  Google Scholar 

  41. Abramowski A, Ward R, Hamdan AH. Neonatal Hypoglycemia, in Treasure Island (FL): StatPearls Publishing, 2023.

  42. Zanetti M, et al. Informatics Methodology used in the web-based Portal of the NASCITA Cohort Study: development and implementation study. J Med Internet Res. 2021;23(3):e23087.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Liu Q, et al. Risk factors and complications of small for gestational age. Pak J Med Sci. 2019;35(5):1199–203.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Darland NW, Harris CC. Perinatal asphyxia and neonatal hypoglycemia: the importance of nursing management. Issues Health Care Women. 1983;4(4–5):273–82.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

None.

Funding

This work was supported by 2023 Corps Science and Technology Program Project (2023CB017-02) and Hangzhou Medical Science and Technology Program Project(A20200779).

Author information

Authors and Affiliations

  1. Department of Neonatology, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, P. R. China

    Dandan Wang

  2. Department of Neonatology, The First Division Hospital of Xinjiang Production and Construction Corps, Akesu, P. R. China

    Xuchen Zhou, Juan Ning, Fen He & Junhui Shi

  3. Department of Gastroenterology, Hangzhou Children’s Hospital, 195#, Wen Hui Road, Gong Shu Distric, Hangzhou, Zhejiang, 310014, P. R. China

    Xuefeng Jin

Authors
  1. Dandan Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xuchen Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Juan Ning
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fen He
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Junhui Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xuefeng Jin
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Design of the work—XJ and DW. Article retrieval and data collection—JS and JN. Article selection—JS, JN and FH. Data analysis, code writing and mapping—DW and XZ. Supervision conducted and responsibility for the entire study—XJ. Drafting the manuscript and revising it—all authors.

Corresponding author

Correspondence to Xuefeng Jin.

Ethics declarations

Ethics approval and consent to participate

All analyses were based on previously published studies; thus, no ethical approval is required.

Consent for publication

Not required.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Supplementary Material 2

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, D., Zhou, X., Ning, J. et al. Risk factors for neonatal hypoglycemia: a meta-analysis. BMC Endocr Disord 24, 166 (2024). https://doi.org/10.1186/s12902-024-01700-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12902-024-01700-7

Keywords

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us